TY - JOUR
T1 - Endothelial cell (EC)-specific Ctgf/Ccn2 expression increases EC reprogramming and atherosclerosis
AU - Li, Feifei
AU - Kumar, Sandeep
AU - Pokutta-Paskaleva, Anastassia
AU - Kang, Dong won
AU - Kim, Chanwoo
AU - Raykin, Julia
AU - Omojola, Victor
AU - Hoffmann, Carson
AU - Zhao, Fujie
AU - Teichmann, Maiko
AU - Park, Christian
AU - In Baek, Kyung
AU - Sanchez Marrero, Gloriani
AU - Ma, Jing
AU - Yanagisawa, Hiromi
AU - Leask, Andrew
AU - Timmins, Lucas
AU - Cui, Xiangqin
AU - Sutliff, Roy
AU - Gleason, Rudy L.
AU - Jo, Hanjoong
AU - Brewster, Luke P.
N1 - Published by Elsevier B.V.
PY - 2025/4
Y1 - 2025/4
N2 - Arterial endothelial cells (ECs) reside in a complex biomechanical environment. ECs sense and respond to wall shear stress. Low and oscillatory wall shear stress is characteristic of disturbed flow and commonly found at arterial bifurcations and around atherosclerotic plaques. Disturbed flow is pro-inflammatory to ECs. Arteries also stiffen with aging and/or the onset of vascular disease. ECs sense and respond to stiffening in a pro-fibrotic manner. Thus, flow and stiffening disturbances elicit EC responses that promote pathologic arterial remodeling. However, the pathways elicited by ECs under pathologic stiffening and disturbed flow are not well understood. The objective of this work was to discover and test the modifiability of key pathways in ECs. To do this we used the partial carotid ligation model to impose disturbed flow onto the precociously stiffened fibulin-5 knockout (Fbln5-/-) mouse carotid arteries. Biomechanical testing demonstrated that Fbln5-/- arteries under disturbed flow approximate the stiffness ratio of diseased human arteries, and the ECs in these Fbln5-/- arteries underwent rapid reprogramming via endothelial to mesenchymal transition (EndMT). Under atherogenic conditions, disturbed flow Fbln5-/- arteries developed more vulnerable plaques than the wild type (WT) mouse arteries. Connective tissue growth factor/cellular communication network factor 2 (Ctgf/Ccn2) was upregulated in vivo in ECs with aging, with stiffening in the Fbln5-/- arteries, and increased again by disturbed flow under stiffened conditions, supporting CTGF as a key biomarker for flow and stiffening. This was validated by immunohistochemistry, which demonstrated increased CTGF deposition in areas of disturbed flow in patient carotid endarterectomy and peripheral artery disease (PAD) specimens. Finally, to test the role of CTGF in regulating and combining these processes, we created an EC-specific Ctgf knockout (Ctgfecko). We identified that carotid arteries under disturbed flow and atherogenic conditions in male Ctgfecko, but not female, mice had decreased plaque area compared to WT control mice. We then tested the Ctgf expression in the carotid endothelium exposed to disturbed or stable flow in WT and Fbln5-/- mice. Here we found that under disturbed flow male mice had greater Ctgf expression than female mice. This work demonstrates that stiffened + disturbed flow conditions drive EC reprogramming, that CTGF is increased by these conditions, and that this increase is more prominent in male carotid arteries. Future exploration of sex-based differences in these fibrotic pathways are warranted to develop targeted therapeutics to limit pathologic arterial remodeling under pathologically stiffened + disturbed flow environments.
AB - Arterial endothelial cells (ECs) reside in a complex biomechanical environment. ECs sense and respond to wall shear stress. Low and oscillatory wall shear stress is characteristic of disturbed flow and commonly found at arterial bifurcations and around atherosclerotic plaques. Disturbed flow is pro-inflammatory to ECs. Arteries also stiffen with aging and/or the onset of vascular disease. ECs sense and respond to stiffening in a pro-fibrotic manner. Thus, flow and stiffening disturbances elicit EC responses that promote pathologic arterial remodeling. However, the pathways elicited by ECs under pathologic stiffening and disturbed flow are not well understood. The objective of this work was to discover and test the modifiability of key pathways in ECs. To do this we used the partial carotid ligation model to impose disturbed flow onto the precociously stiffened fibulin-5 knockout (Fbln5-/-) mouse carotid arteries. Biomechanical testing demonstrated that Fbln5-/- arteries under disturbed flow approximate the stiffness ratio of diseased human arteries, and the ECs in these Fbln5-/- arteries underwent rapid reprogramming via endothelial to mesenchymal transition (EndMT). Under atherogenic conditions, disturbed flow Fbln5-/- arteries developed more vulnerable plaques than the wild type (WT) mouse arteries. Connective tissue growth factor/cellular communication network factor 2 (Ctgf/Ccn2) was upregulated in vivo in ECs with aging, with stiffening in the Fbln5-/- arteries, and increased again by disturbed flow under stiffened conditions, supporting CTGF as a key biomarker for flow and stiffening. This was validated by immunohistochemistry, which demonstrated increased CTGF deposition in areas of disturbed flow in patient carotid endarterectomy and peripheral artery disease (PAD) specimens. Finally, to test the role of CTGF in regulating and combining these processes, we created an EC-specific Ctgf knockout (Ctgfecko). We identified that carotid arteries under disturbed flow and atherogenic conditions in male Ctgfecko, but not female, mice had decreased plaque area compared to WT control mice. We then tested the Ctgf expression in the carotid endothelium exposed to disturbed or stable flow in WT and Fbln5-/- mice. Here we found that under disturbed flow male mice had greater Ctgf expression than female mice. This work demonstrates that stiffened + disturbed flow conditions drive EC reprogramming, that CTGF is increased by these conditions, and that this increase is more prominent in male carotid arteries. Future exploration of sex-based differences in these fibrotic pathways are warranted to develop targeted therapeutics to limit pathologic arterial remodeling under pathologically stiffened + disturbed flow environments.
KW - Arterial stiffening
KW - Atherosclerotic plaque
KW - Connective tissue growth factor/CCN2
KW - Endothelial cells
KW - Fibulin-5
KW - Flow-mediated arterial remodeling
KW - Sex-differences
KW - Carotid Arteries/metabolism
KW - Humans
KW - Stress, Mechanical
KW - Male
KW - Mice, Knockout
KW - Atherosclerosis/metabolism
KW - Animals
KW - Endothelial Cells/metabolism
KW - Calcium-Binding Proteins/metabolism
KW - Plaque, Atherosclerotic/metabolism
KW - Connective Tissue Growth Factor/metabolism
KW - Epithelial-Mesenchymal Transition
KW - Mice
KW - Vascular Stiffness
KW - Disease Models, Animal
UR - http://www.scopus.com/inward/record.url?scp=85216846356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85216846356&partnerID=8YFLogxK
U2 - 10.1016/j.matbio.2025.01.003
DO - 10.1016/j.matbio.2025.01.003
M3 - Article
C2 - 39818254
AN - SCOPUS:85216846356
SN - 0945-053X
VL - 136
SP - 102
EP - 110
JO - Matrix Biology
JF - Matrix Biology
ER -